MedPath
FDA Approval

Cholestyramine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Ajanta Pharma USA Inc.
DUNS: 557554156
Effective Date
November 23, 2021
Labeling Type
Human Prescription Drug Label
Cholestyramine(4 g in 9 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Ajanta Pharma Limited

918594859

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Ajanta Pharma Ltd., Dahej

Ajanta Pharma USA Inc.

Ajanta Pharma Limited

862199968

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cholestyramine

Product Details

NDC Product Code
27241-134
Application Number
ANDA211119
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 23, 2021
Code: 4B33BGI082Class: ACTIBQuantity: 4 g in 9 g
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0CClass: IACT
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
© Copyright 2025. All Rights Reserved by MedPath